Results 191 to 200 of about 320,211 (227)

Operational stability of mixed Sn–Pb perovskite solar cells: Mechanisms, mitigation strategies, and perspectives

open access: yesBulletin of the Korean Chemical Society, EarlyView.
This review consolidates mechanisms and solutions for mixed Sn–Pb perovskite solar cells. It identifies Sn2+ oxidation, iodine generation, and interfacial defects as primary instabilities. It discusses progress in additives, interface passivation, alternative hole transport layers, and solvent engineering as well as future directions for achieving long‐
Lei Chen, Kai Zhu
wiley   +1 more source

Understanding cationic polyelectrolyte thermogels with varying charge densities toward biomaterials design

open access: yesBMEMat, EarlyView.
Cationic polyurethane thermogels with customizable charge density were developed, exhibiting enhanced pH‐responsiveness. This work elucidates how cationic charges influence self‐assembly and thermogelling, providing insights for designing smart biomaterials.
Belynn Sim   +10 more
wiley   +1 more source

Protein kinase a regulates cyclooxygenase-2 expression through the RNA-binding proteins HuR and TTP. [PDF]

open access: yesJ Biol Chem
Adame-Garcia SR   +8 more
europepmc   +1 more source

Eudragit®‐engineered pH‐responsive probiotic microspheres with enhanced gastrointestinal resistance and prolonged storage stability for inflammatory bowel disease therapy

open access: yesBMEMat, EarlyView.
This study reports the development of AMS@Eud core‐shell microspheres, combining calcium alginate and pH‐responsive Eudragit® L100, which exhibit exceptional gastrointestinal resistance and long‐term storage stability (only 5.28%–9.09% viability loss over 35 days at 4–25°C), and effectively alleviate inflammatory bowel disease via gut microbiota ...
Ming Teng   +5 more
wiley   +1 more source

Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia

open access: yesBMEMat, EarlyView.
CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy